ロード中...
Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers
BACKGROUND: Plasma cfDNA evaluation at acquired resistance to targeted therapies in lung cancer is routine, however, reports of extended clinical application and pitfalls in laboratory practice are still limited. In this study we describe our experience with cfDNA testing using EGFR T790M as a proto...
保存先:
| 出版年: | Acta Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480496/ https://ncbi.nlm.nih.gov/pubmed/31347936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0284186X.2019.1645354 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|